Inhibition of the Raf/Mek/P-Erk pathway for treating cancer

Authors

Said M. Sebti

Document Type

Patent

Publication Date

May 2010

Patent Number

7713960

Abstract

The invention disclosed herein provides for methods of treating cancer using inhibitors of the Raf/Mek/P-Erk 1/2 pathway. These inhibitors include B2AR agonists (such as ARA-211 (pirbuterol) and isoproterenol), adenylyl cyclase activators, cAMP analogs and Epac activators. The invention also provides methods for diagnosing cancer in an individual.

Application Number

11/490,777

Recommended Citation

Sebti, Said M., "Inhibition of the Raf/Mek/P-Erk pathway for treating cancer" (2010). USF Patents. 485.
https://digitalcommons.usf.edu/usf_patents/485

Assignees

University of South Florida

Filing Date

07/21/2006

Primary/U.S. Class

514/217